FDA-approved epilepsy drug may help reverse osteoarthritis damage
Thursday, October 8, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies. (via Science Daily)
Read the Full StoryThis article will expire in 28 days.
In the News...
View All Recent News
- Nearly 30,000 people tested quit-smoking methods. One stood out
- Scientists tested 5 natural compounds on cancer cells. One stood out
- Bacteria turn a virus’ own weapon against it
- Only one workout helped older adults lose fat and keep muscle
- Just 7 days of strength training started shrinking fat cells in mice
- FDA-approved epilepsy drug may help reverse osteoarthritis damage
- Stanford scientists turn a cancer driver into a kill switch
- Dads are dying after their kids are born, and almost no one is tracking it
- Not all trans fats are bad, major review finds
- Scientists warn a popular vitamin D supplement may have a hidden downside
- Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
- Scientists reprogram immune cells inside the body to fight cancer
- Taking antibiotics? Sugar may be making the damage worse
- What happens in the brain when cannabis makes you anxious?
- A new way to fight gum disease without wiping out good bacteria
- A few drops of this Japanese tree oil may help you sleep more soundly
- MIT scientists find a hidden cancer risk of the keto diet
- One simple addition to postpartum care made a major difference
- Colorectal cancer is rising in young people and often found too late
- Scientists say this simple habit could strengthen your marriage